BNE0 Stock Chart & Stats
€0.94
€0.09(8.74%)
At close: 4:00 PM EDT
€0.94
€0.09(8.74%)
Day’s Range― - ―
52-Week Range€0.85 - €1.60
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€11.14M
Enterprise Value€52.20
Total Cash (Recent Filing)€866.46K
Total Debt (Recent Filing)€28.95M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Nov 18, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding12,692,942
10 Day Avg. Volume12
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)-4.05
Price to Sales (P/S)10.37
P/FCF Ratio-2.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)€7.22M
Bulls Say, Bears Say
Bulls Say
Revenue And Customer AdoptionRapid sequential and year-over-year revenue growth, combined with repeat purchasing from 40 active customers, indicates that Burcon’s ingredients are gaining commercial acceptance. Continued conversion from evaluation to recurring orders could create a more durable revenue base as customer applications expand.
Scalable Product PlatformA portfolio spanning sunflower, pea, fava and canola proteins demonstrates that Burcon’s technology applies across multiple plant sources and food applications. Product breadth and repeated production records can support broader customer penetration and reduce reliance on a single ingredient.
Structural Protein DemandLong-term dietary shifts and expanding demand for protein ingredients provide a structural market backdrop for Burcon’s specialty products. A sizable identified growth opportunity in North America could support sustained customer additions and volume expansion if the company executes effectively.
Bears Say
Deep UnprofitabilityBurcon’s substantial negative margins show that current revenue is not covering the cost base, so growth has not yet produced operating leverage. Persistent losses reduce internal funding capacity and make the business more dependent on successful scaling, cost control and future financing.
Weak Cash GenerationOngoing operating and free-cash-flow deficits indicate that Burcon is consuming cash while building its commercial platform. Continued burn can constrain investment in production and commercialization, while increasing the need to secure external capital before operations become self-funding.
Leveraged And Eroded Balance SheetNegative equity and debt exceeding the asset base signal limited financial flexibility and elevated balance-sheet risk. This structure may restrict Burcon’s ability to absorb setbacks, fund capacity expansion internally or negotiate from strength with lenders and commercial partners.
Burcon Nutrascience News
BNE0 FAQ
What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was €0.85 and its highest was €1.60 in the past 12 months.
What is Burcon Nutrascience’s market cap?
Burcon Nutrascience’s market cap is €11.14M.
When is Burcon Nutrascience’s upcoming earnings report date?
Burcon Nutrascience’s upcoming earnings report date is Nov 18, 2026 which is in 63 days.
How were Burcon Nutrascience’s earnings last quarter?
Burcon Nutrascience released its earnings results on Aug 12, 2026. The company reported -€0.186 earnings per share for the quarter, missing the consensus estimate of -€0.043 by -€0.143.
Is Burcon Nutrascience overvalued?
According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued.
Does Burcon Nutrascience pay dividends?
Burcon Nutrascience does not currently pay dividends.
What is Burcon Nutrascience’s EPS estimate?
Burcon Nutrascience’s EPS estimate is -0.11.
How many shares outstanding does Burcon Nutrascience have?
Burcon Nutrascience has 12,692,942 shares outstanding.
What happened to Burcon Nutrascience’s price movement after its last earnings report?
Burcon Nutrascience reported an EPS of -€0.186 in its last earnings report, missing expectations of -€0.043. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Burcon Nutrascience?
Currently, no hedge funds are holding shares in DE:BNE0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Burcon Nutrascience
Burcon NutraScience Corporation, along with its associated entities, is a Canadian enterprise specializing in the development and commercialization of plant-derived proteins and functional ingredients for the food and beverage sectors. Its extensive product line features Peazazz, a versatile pea protein suitable for a range of applications including dairy alternatives, ready-to-drink and dry-blended beverages, snack bars, baked goods, and meat substitutes. Also derived from peas, Peazac and Peazac 850 are tailored for plant-based meat alternatives, ready-to-mix powders and drinks, dairy-free options, and nutritional bars, particularly valued for their neutral taste profile and moderate textural properties. Among its canola-based proteins is Puratein, an isolate frequently utilized in meat alternatives such as burgers and sausages, as well as nutrition bars. Supertein, a pale-hued canola protein powder, is incorporated into non-dairy frozen desserts, egg replacers, plant-based marshmallows, ready-to-mix beverages, whipped toppings, and plant-based snack bars. Additionally, Nutratein, a canola protein composed of globulin and albumin, finds utility in meat and egg alternatives, alongside various other functional plant-based foods. Further expanding its offerings are Nutratein-PS and Nutratein-TZ, custom blends featuring its Peazac pea protein, alongside CLARISOY, a soy protein employed across sports nutrition beverages, citrus and fruit-flavored drinks, lemonades, powdered beverage mixes, and diverse other food and dietary items. Finally, MeritPro stands as a unique nutritional protein blend, distinguished by being allergen-free, gluten-free, dairy-free, non-GMO, and vegan-friendly. Originally incorporated in 1998 as Burcon Capital Corp., the firm rebranded to Burcon NutraScience Corporation in October 1999. Its corporate headquarters are situated in Vancouver, Canada.
BNE0 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was constructive and execution-focused: management reported strong sequential and year-over-year revenue growth (54% QoQ; >3x YoY), growing customer adoption with 40 active buyers and repeat purchases, production scaling across multiple products, and put in place financing (up to $8.1M convertible debentures plus $3M undrawn tranche) to expand capacity and pursue near-term targets. Material risks remain — the company is still unprofitable, depends on additional funding and capacity expansions, and growth is back-end loaded and contingent on converting its sales funnel. On balance, the positives around commercial validation, production progress and committed financing outweigh the risks, although execution and timing remain key.View all DE:BNE0 earnings summaries





